Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
566-01-013 ISMRM Abstract

Faster cerebral blood flow reduction is associated with amyloid burden and cognitive decline: a longitudinal study

Primary: Neuro - Alzheimer's Disease
Secondary: Neuro - Gray Matter
566-01-013 · Detectable Changes in Dementia · Wednesday, 13 May, 8:20 AM–9:15 AM · Digital Posters Row G
Keywords: Alzheimer's Disease Cerebral blood flow Cognitive Function Amyloid PET 3D-PCASL MRI
Accepted
Tianrui Zhao1,2, Samantha T Nimmo3, Steven Cen4, Jianing Tang1,2, Sang Hun Chung 2, Elizabeth Joe4, Meredith N Braskie3,4, Helena Chui4, Vasilis Z Marmarelis5, Lirong Yan1,2
1Biomedical Engineering, Northwestern University, Chicago, United States of America
2Radiology, Northwestern University, Chicago, United States of America
3USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, United States of America
4Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, United States of America
5Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, United States of America
Presenting Author: Sang Hun Chung

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Wolk DA, Detre JA. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Current opinion in neurology. 2012 Aug 1;25(4):421-8.doi: 10.1097/WCO.0b013e328354ff0a. [doi]
2. Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C, Calaminus C, Stahlschmidt A, Ye L, Burnet M, Stiller D. Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nature medicine. 2014 Dec;20(12):1485-92.doi: 10.1038/nm.3734. [doi]
3. Van Der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CL, Scheltens P. Vascular cognitive impairment. Nature reviews Disease primers. 2018 Feb 15;4(1):1-6.doi: 10.1038/nrdp.2018.3. [doi]
4. Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain. 2016 Nov 1;139(11):2957-69.doi: 10.1093/brain/aww214. [doi]
5. Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez‐Garcia L, Lu H, MacIntosh BJ, Parkes LM, Smits M, Van Osch MJ. Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic resonance in medicine. 2015 Jan;73(1):102-16.doi: 10.1002/mrm.25197. [doi]
6. Hernandez‐Garcia L, Aramendía‐Vidaurreta V, Bolar DS, Dai W, Fernández‐Seara MA, Guo J, Madhuranthakam AJ, Mutsaerts H, Petr J, Qin Q, Schollenberger J. Recent technical developments in ASL: a review of the state of the art. Magnetic resonance in medicine. 2022 Nov;88(5):2021-42.doi: 10.1002/mrm.29381. [doi]
7. Vemuri P, Lowe VJ, Knopman DS, Senjem ML, Kemp BJ, Schwarz CG, Przybelski SA, Machulda MM, Petersen RC, Jack Jr CR. Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017 Jan 1;6:21-30. doi: 10.1016/j.dadm.2016.12.010. [doi]
8. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005 Apr;53(4):695-9.doi: 10.1111/j.1532-5415.2005.53221.x. [doi]
9. Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Archives of general psychiatry. 1983 Jul 1;40(7):812-. doi: 10.1001/archpsyc.1983.01790060110016. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/566-01-013